TRCT
HIMS icon

Tower Research Capital (TRC)’s Hims & Hers Health HIMS Stock Holding History

Tower Research Capital (TRC)’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Buy
111,351
+94,634
+566% +$2.54M 0.09% 192
2026
Q1 		$347K Buy
16,717
+1,490
+10% +$35.2K 0.01% 1196
2025
Q4 		$494K Sell
15,227
-13,574
-47% -$581K 0.01% 835
2025
Q3 		$1.63M Sell
28,801
-9,484
-25% -$486K 0.05% 342
2025
Q2 		$1.91M Buy
38,285
+13,473
+54% +$609K 0.05% 320
2025
Q1 		$733K Buy
24,812
+6,810
+38% +$253K 0.02% 646
2024
Q4 		$435K Buy
18,002
+7,476
+71% +$185K 0.01% 1161
2024
Q3 		$194K Sell
10,526
-12,781
-55% -$229K 0.01% 1653
2024
Q2 		$471K Buy
23,307
+15,527
+200% +$258K 0.01% 1396
2024
Q1 		$120K Sell
7,780
-16,648
-68% -$188K ﹤0.01% 1727
2023
Q4 		$217K Buy
24,428
+22,247
+1,020% +$164K ﹤0.01% 2038
2023
Q3 		$13.7K Sell
2,181
-1,496
-41% -$11.1K ﹤0.01% 3761
2023
Q2 		$34.6K Sell
3,677
-15,515
-81% -$154K ﹤0.01% 2894
2023
Q1 		$190K Buy
19,192
+12,888
+204% +$113K 0.01% 1395
2022
Q4 		$41K Sell
6,304
-3,234
-34% -$18.4K ﹤0.01% 2494
2022
Q3 		$54K Buy
9,538
+3,933
+70% +$23.7K ﹤0.01% 3096
2022
Q2 		$25K Buy
+5,605
New +$23.9K ﹤0.01% 3555
2022
Q1 		– Sell
-690
Closed -$5K – 6274
2021
Q4 		$5K Buy
690
+621
+900% +$4.49K ﹤0.01% 5153
2021
Q3 		$1K Buy
+69
New +$584 ﹤0.01% 5481
2021
Q2 		– Sell
-171
Closed -$2K – 5624
2021
Q1 		$2K Sell
171
-1,373
-89% -$23K ﹤0.01% 5021
2020
Q4 		$23K Buy
+1,544
New +$17.1K ﹤0.01% 3772

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Tower Research Capital (TRC)'s HIMS Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Hims & Hers Health (HIMS) stake by 566% in Q2 2026, buying an estimated $2.54M and bringing the position to 111,351 shares worth $3.86M. The position accounts for 0.09% of the portfolio, ranked #192.

Tower Research Capital (TRC) first reported a position in HIMS in Q4 2020 and has held it in 21 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Tower Research Capital (TRC) held 111,351 shares of Hims & Hers Health worth $3.86M as of Q2 2026.
  • Tower Research Capital (TRC) bought 94,634 Hims & Hers Health shares in Q2 2026, an estimated $2.54M.
  • Hims & Hers Health made up 0.09% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #192 holding.
  • Tower Research Capital (TRC) first reported a position in Hims & Hers Health in Q4 2020 and has held it in 21 quarters since.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.